• Produktbild: SARS-CoV-2 Variants and Global Population Vulnerability
  • Produktbild: SARS-CoV-2 Variants and Global Population Vulnerability

SARS-CoV-2 Variants and Global Population Vulnerability Diagnostic Strategies, Vaccine Development, and Therapeutic Management

354,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

05.07.2024

Abbildungen

farbige, schwarzweisse Abbildungen

Herausgeber

Vivek P. Chavda + weitere

Verlag

Taylor and Francis

Seitenzahl

614

Maße (L/B/H)

24/16,1/3,7 cm

Gewicht

1077 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-77491-758-9

Beschreibung

Portrait

Vivek P. Chavda, MPharm, is currently working as an Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, Ahmedabad, Gujarat, India. Before joining academia, he served in the biologics industry for almost eight years in research and development with two successful regulatory filings at Lupin Biotech (Pune) and Dr. Reddy‘s Laboratory (Hyderabad). He has more than 150 national and international publications, nearly 20 book chapters, several books, one patent in progress as well as numerous newsletter articles to his credit. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He earned his BPharm and MPharm degrees (with gold medals) at Gujarat Technological University, Gujarat, India.

Vladimir N. Uversky, PhD, DSc, FRSB, FRSC, is a full Professor in the Department of Molecular Biology, University of South Florida, Tampa, Florida, USA. Dr. Uversky works on various aspects of protein intrinsic disorder phenomenon and on analysis of protein folding and misfolding. He has authored over 1150 scientific publications. According to the Thomson Reuters’ Web of Science, his work was cited over 66,000 times, and he has an h-index of 126. Dr. Uversky has been included in the prestigious Clarivate List of Highly Cited Researchers™ every year from 2014 to 2020. In 2021, he was elected as a Fellow of the Royal Society of Biology and a Fellow of the Royal Society of Chemistry. Over the years, he has delivered more than 240 invited talks at various national and international conferences and invited seminars in various universities and research institutions around the globe. Dr. Uversky has collaborated with more than 12,500 colleagues from more than 2,750 research organizations in 89 countries/territories. He is an editor of a number of scientific journals and has edited several books and book series on protein structure, function, folding, and misfolding. He obtained his PhD in Biophysics from the Moscow Institute of Physics and Technology and DSc in Biophysics from the Institute of Experimental and Theoretical Biophysics, Russian Academy of Sciences.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

05.07.2024

Abbildungen

farbige, schwarzweisse Abbildungen

Herausgeber

Verlag

Taylor and Francis

Seitenzahl

614

Maße (L/B/H)

24/16,1/3,7 cm

Gewicht

1077 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-77491-758-9

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben: Einfach Barcode scannen, Versandetikett ausdrucken, Bücher verschicken und Thalia Geschenkkarte erhalten.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: SARS-CoV-2 Variants and Global Population Vulnerability
  • Produktbild: SARS-CoV-2 Variants and Global Population Vulnerability
  • Foreword by Elrashdy M. Redwan 1. Zoonotic Origin, Genomic Organization, Transmission, and Mutation of SARS-CoV-2 2. SARS-CoV-2 Life Cycle and Immuno-Pathophysiology 3. Conventional and Novel Diagnostics for the Detection of SARS-CoV-2 Variants 4. Biosensors: An Advanced and Sensitive Analytical Technique for the Early Detection of SARS-CoV-2 Variants 5. Global Impact of Delta and Omicron Variants of SARS-CoV-2 6. Drug Repurposing for Covid-19 and Fast Track New Drug Discovery for Emerging SARS-CoV-2 Variants 7. Characterization of SARS-CoV-2 Variants Using Respiratory Organoids and Organs on a Chip (OOACs) 8. Fast-Track Vaccine Development for Covid-19 and Impact of Emerging Variants 9. Nasal Vaccine for the Control of Emerging Variants of SARS-CoV-2 10. Role of Nucleic Acid Vaccines for the Management of Emerging Variants of SARS-CoV-2 11. Role of Monoclonal Antibodies for the Management of Immersing Variant of SARS-CoV-2 12. Dietary Supplements and Nutraceuticals Against Variants of SARS-CoV-2 13. Herbal Remedies for Covid-19 Management 14. Covid-19 and Post-Covid-19 Associated Complications and Their Management 15. SARS-CoV-2 Variants and Global Vulnerability: Diagnostic, Vaccines, and Therapeutic Management 16. Socio-Economic and Environmental Impact of SARS-CoV-2 Variants 17. Nanotechnology-Based Interventions for Covid-19 Management 18. SARS-CoV-2 Variants and Covid-19 Pandemic: Future Perspectives